医学
养生
放化疗
肿瘤科
阶段（地层学）
肺癌
内科学
护理标准
总体生存率
古生物学
生物
作者
Jiakang Li,Jingyan Xu,Mingyi Yang,Qing Zhou
标识
DOI：10.20892/j.issn.2095-3941.2022.0254
摘要
In the past, chemoradiotherapy (CRT) has been the standard of care for inoperable stage III NSCLC. Concurrent chemoradiotherapy (cCRT), if tolerable in patients, is the optimal treatment regimen. A meta-analysis has shown that cCRT results in a 5-year survival rate 4.5% longer than that with
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
changping
tuanheqi
zcl
小青椒
Smar_zcl
wlscj
lalala
star
小杭76
Tourist
风中冰香
哈基米德
个性的紫菜
GingerF
Criminology34
那时花开
LB
机灵班
凤凰
electricelectric
子车茗
eric888
及禾
皖公网安备34019202002308
